Recent events
Recent events tied to this brand in public sources.
Back to profile4 entries
2026
CSL appoints Deborah Waterhouse as CEO and Managing Director
CSL announced that it had appointed Deborah Waterhouse as Chief Executive Officer and Managing Director, with the appointment to take effect on 1 February 2027. Gordon Naylor will continue as Interim CEO and Managing Director until then.
2021
CSL completes A$6.3 billion institutional placement
CSL Limited announced the completion of a $6.3 billion institutional placement, with proceeds intended to support its acquisition of Vifor Pharma.
2021
UniQuest partners with CSL to advance potential therapy development
UniQuest partnered with CSL to accelerate development of a potential treatment for blood vessels damaged by inflammation. The technology is to advance to pre-clinical studies with $500,000 from CSL's Research Acceleration Initiative.
2020
CSL and Takeda join forces to develop a COVID-19 plasma treatment
CSL joined forces with Takeda to develop a COVID-19 plasma treatment using antibodies from recovered patients to help seriously ill people.